医药行业分析
- (2023-01-12)
- (2023-01-12)
- (2023-01-12)
- (2023-01-12)
- (2023-01-12)
- (2023-01-11)
- (2023-01-11)
- (2023-01-11)
- (2023-01-11)
- (2023-01-11)
- (2023-01-11)
- (2023-01-11)
- (2023-01-11)
- (2023-01-11)
- (2023-01-10)
- (2023-01-10)
- (2023-01-10)
- (2023-01-10)
- (2023-01-10)
- (2023-01-10)
- (2023-01-10)
- (2023-01-10)
- (2023-01-09)
- (2023-01-09)
- (2023-01-09)
- (2023-01-09)
- (2023-01-09)
- (2023-01-09)
- (2023-01-08)
- (2023-01-08)
- (2023-01-07)
- (2023-01-06)
- (2023-01-06)
- (2023-01-06)
- (2023-01-06)
- (2023-01-06)
- (2023-01-06)
- (2023-01-06)
- (2023-01-05)
- (2023-01-05)
- (2023-01-05)
- (2023-01-05)
- (2023-01-05)
- (2023-01-05)
- (2023-01-05)
- (2023-01-05)
- (2023-01-04)
- (2023-01-04)
- (2023-01-03)
- (2023-01-03)
- (2023-01-03)
- (2023-01-03)
- (2023-01-03)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
Molecular Cancer : YAP调控一种谱系特异性NeuRegin1通路驱动的对RAF激酶抑制剂的适应性抵抗
(2022-12-30)